ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CAPN3 | Calpain 3, (p94) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CEP85 | Centrosomal protein 85kDa | Predicted intracellular proteins
| | | | | Tissue enhanced |
CHRNA1 | Cholinergic receptor, nicotinic, alpha 1 (muscle) | Disease related genes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CORO6 | Coronin 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FLNC | Filamin C, gamma | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FNDC5 | Fibronectin type III domain containing 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
HOXC10 | Homeobox C10 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HSPB6 | Heat shock protein, alpha-crystallin-related, B6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MACROD1 | MACRO domain containing 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
MYF5 | Myogenic factor 5 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MYH8 | Myosin, heavy chain 8, skeletal muscle, perinatal | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NANOS1 | Nanos homolog 1 (Drosophila) | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
P2RX6 | Purinergic receptor P2X, ligand-gated ion channel, 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
PACSIN3 | Protein kinase C and casein kinase substrate in neurons 3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PDLIM3 | PDZ and LIM domain 3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PHKA1 | Phosphorylase kinase, alpha 1 (muscle) | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PROB1 | Proline-rich basic protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMYD1 | SET and MYND domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SYNPO | Synaptopodin | Predicted intracellular proteins
| | | | | Tissue enhanced |
TCF15 | Transcription factor 15 (basic helix-loop-helix) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TEAD4 | TEA domain family member 4 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |